GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

UHT · Jun 30, 2024

UNIVERSAL HEALTH REALTY INCOME TRUST. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000950170-24-094044Reit
Operating-cash-flow growth75thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.operating_cash_flow

-1.04% · OPTIONAL · VALID

Net-income growth100thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.net_income

51.78% · CORE · VALID

Revenue growth0thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.revenue

3.90% · CORE · VALID

Cash and equivalents0thOwn-history percentile · N=12
Evidence method

Level · gp.fundamentals.cash

$5.6M · CORE · VALID

Operating-income growth100thOwn-history percentile · N=8
Evidence method

Yoy · gp.fundamentals.operating_income

29.79% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History17 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
16.59%
Current
-1.04%
Delta
-17.62%
Earnings Growth Increased
Previous
18.86%
Current
51.78%
Delta
32.92%
Growth Decreased
Previous
8.25%
Current
3.90%
Delta
-4.35%
Liquidity Decreased
Previous
$7.7M
Current
$5.6M
Delta
-$2.1M
Profitability Increased
Previous
21.55%
Current
29.79%
Delta
8.24%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.